<?xml version="1.0" encoding="UTF-8"?>
<snippetsTree>
 <snippets file="drug\PMC7291320\results\search\country\results.xml">
  <result pre="severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2) occurred in Wuhan," exact="China" post="with further worldwide transmission to a pandemic outbreak. An"/>
  <result pre="similar to SARS-CoV [27,28]. According to the retrospective study from" exact="China" post="including 191 patients with COVID-19, the median time from"/>
  <result pre="storms in critically ill patients [8]. Large case series from" exact="China" post="including 72,314 patients with COVID-19 have indicated that the"/>
  <result pre="[32]. Recent investigation has demonstrated a higher mortality rate in" exact="Italy" post="(7.2%) than in China (2.3%), which could be due"/>
  <result pre="demonstrated a higher mortality rate in Italy (7.2%) than in" exact="China" post="(2.3%), which could be due to the older age"/>
  <result pre="which could be due to the older age distribution in" exact="Italy" post="relative to that in China [33]. Importantly, 3.8% of"/>
  <result pre="the older age distribution in Italy relative to that in" exact="China" post="[33]. Importantly, 3.8% of the whole cohort were health"/>
  <result pre="severe or critical [32]. Lately, increasing numbers of reports from" exact="the United States" post="(U.S.) have linked obesity to more severe COVID-19 illness"/>
  <result pre="or critical [32]. Lately, increasing numbers of reports from the" exact="United States" post="(U.S.) have linked obesity to more severe COVID-19 illness"/>
  <result pre="[33]. The high proportion of older patients with COVID-19 in" exact="Italy" post="(patients 70 years or older; 37.6% in Italy vs."/>
  <result pre="COVID-19 in Italy (patients 70 years or older; 37.6% in" exact="Italy" post="vs. 11.9% in China) was considered the main determinant"/>
  <result pre="previously referenced analysis of 44,672 confirmed COVID-19 cases from Wuhan," exact="China" post="were noted in patients with CVD (10.5%), DM (7.3%),"/>
  <result pre="by CT, indicating cardiac inflammation [55]. An early report from" exact="China" post="demonstrated that the late increase of hs-cTnI in nonsurvivors"/>
  <result pre="[7]. Moreover, the first description of critically ill patients from" exact="the United States" post="indicated that 33% of the ICU patients developed cardiomyopathy"/>
  <result pre="Moreover, the first description of critically ill patients from the" exact="United States" post="indicated that 33% of the ICU patients developed cardiomyopathy"/>
  <result pre="only one retrospective registry cohort of 25 COVID-19 patients in" exact="China" post="with CT pulmonary angiography suggested a high rate of"/>
  <result pre="required for virus/cell fusion [104]. A small single-arm study from" exact="France" post="has tested the effect of hydroxychloroquine (an analogue of"/>
  <result pre="into host cells [17]. This drug is clinically available in" exact="Japan" post="and is a promising agent to be further tested."/>
 </snippets>
</snippetsTree>
